Literature DB >> 20382049

Topography of the masseter muscle in relation to treatment with botulinum toxin type A.

Kyung-Seok Hu1, Seong-Taek Kim, Mi-Sun Hur, Ju-Hyun Park, Wu-Chul Song, Ki-Seok Koh, Hee-Jin Kim.   

Abstract

OBJECTIVE: The objective of this study was to provide the safest and most efficient site for injection of botulinum toxin type A into the masseter muscle. STUDY
DESIGN: This study was performed on 40 hemifaces from cadavers. The surface of the masseter was compartmentalized into areas I to VIII. Areas I, III, V, and VII were assigned to represent the upper 4 compartments from the posterior aspect of each muscle, and areas II, IV, VI, and VIII were assigned to represent the lower 4 compartments.
RESULTS: The parotid gland usually covered compartments I and II, and the marginal mandibular branch of the facial nerve was located a mean of 7.4 mm above the inferior mandibular margin. The parotid duct was usually located above the reference line connecting the tragus and the cheilion.
CONCLUSION: The center of compartment VI is the safest and most efficient injection site for botulinum toxin type A into the masseter muscle. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382049     DOI: 10.1016/j.tripleo.2009.12.036

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  11 in total

1.  Effects of botulinum toxin on jaw motor events during sleep in sleep bruxism patients: a polysomnographic evaluation.

Authors:  Young Joo Shim; Moon Kyu Lee; Takafumi Kato; Hyung Uk Park; Kyoung Heo; Seong Taek Kim
Journal:  J Clin Sleep Med       Date:  2014-03-15       Impact factor: 4.062

2.  Anatomical recommendations for safe botulinum toxin injection into temporalis muscle: a simplified reproducible approach.

Authors:  Won-Kang Lee; Jung-Hee Bae; Kyung-Seok Hu; Takafumi Kato; Seong-Taek Kim
Journal:  Surg Radiol Anat       Date:  2016-09-08       Impact factor: 1.246

3.  Anatomical Study of the Innervation of the Masseter Muscle and Its Correlation with Myofascial Trigger Points.

Authors:  Roberto Procópio Pinheiro; Matheus Aquesta Gaubeur; Ana Maria Itezerote; Samir Omar Saleh; Flávio Hojaij; Mauro Andrade; Alfredo Luiz Jacomo; Flávia Emi Akamatsu
Journal:  J Pain Res       Date:  2020-12-02       Impact factor: 3.133

4.  Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.

Authors:  Fernanda Homem de Mello de Souza Klein; Fabiane Mulinari Brenner; Maurício Shigeru Sato; Fernanda Manfron Batista Rosas Robert; Karin Adriane Helmer
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

5.  Change of distribution and timing of bite force after botulinum toxin type A injection evaluated by a computerized occlusion analysis system.

Authors:  Ji Hee Song; Eunae S Cho; Seong Taek Kim; Hyung Joon Ahn
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

6.  The Anatomical Basis of Paradoxical Masseteric Bulging after Botulinum Neurotoxin Type A Injection.

Authors:  Hyung-Jin Lee; In-Won Kang; Kyle K Seo; You-Jin Choi; Seong-Taek Kim; Kyung-Seok Hu; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2016-12-30       Impact factor: 4.546

7.  Ultrasonographic Considerations for Safe and Efficient Botulinum Neurotoxin Injection in Masseteric Hypertrophy.

Authors:  Hyung-Jin Lee; Su-Jin Jung; Seong-Taek Kim; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2021-01-04       Impact factor: 4.546

8.  Anatomical Considerations When Treating Compensatory Hypertrophy of the Upper Part of the Masseter after Long-Term Botulinum Neurotoxin Type A Injections.

Authors:  Kyu-Lim Lee; Hyun Jin Cho; Hyungkyu Bae; Hyun Jin Park; Min Sun Park; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2020-03-22       Impact factor: 4.546

9.  Botulinum Toxin Therapy for Managing Sleep Bruxism: A Randomized and Placebo-Controlled Trial.

Authors:  Young Joo Shim; Hee Jin Lee; Keun Jeong Park; Hyung Tack Kim; Il Hee Hong; Seong Taek Kim
Journal:  Toxins (Basel)       Date:  2020-03-09       Impact factor: 4.546

10.  Comparison between Conventional Blind Injections and Ultrasound-Guided Injections of Botulinum Toxin Type A into the Masseter: A Clinical Trial.

Authors:  Hyungkyu Bae; Jisoo Kim; Kyle K Seo; Kyung-Seok Hu; Seong-Taek Kim; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2020-09-11       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.